Ignite Creation Date:
2025-12-24 @ 7:04 PM
Ignite Modification Date:
2026-01-04 @ 9:38 AM
Study NCT ID:
NCT02862457
Status:
COMPLETED
Last Update Posted:
2022-08-19
First Post:
2016-08-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-23
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-03
First Submit QC Date:
None
Study First Post Date:
2016-08-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-11-05
Results First Submit QC Date:
None
Results First Post Date:
2022-01-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-17
Last Update Post Date:
2022-08-19
Last Update Post Date Type:
ACTUAL